The Authority in Global Agricultural Chemistry & Bio-Resources
China Scales GMP API Flow Synthesis for EU and US BuyersChina scales GMP API flow synthesis for EU and US buyers, highlighting higher yield, lower solvent use, Part 11 e-records, and remote audit readiness for smarter CDMO sourcing.
Why Pharmaceutical Procurement Risks Are Rising in 2026Pharmaceutical Procurement risks are rising in 2026. Learn how API shortages, regulatory scrutiny, geopolitics, and supplier transparency can reshape resilient sourcing.- How to Cut Pharmaceutical Procurement Costs SafelyPharmaceutical Procurement cost savings start with risk control. Learn safe strategies to reduce spend, protect compliance, strengthen suppliers, and secure supply continuity.
- What Delays Pharmaceutical Procurement Most Often?Pharmaceutical Procurement delays often start with unclear specs, supplier gaps, compliance documents, and logistics risks. Learn how to spot bottlenecks early and protect supply continuity.
- ANVISA Extends Custom Synthesis Oversight to Tier-3 SuppliersANVISA extends custom synthesis oversight to tier-3 suppliers—key for API exporters, CDMOs & pharma procurement teams entering Brazil. Learn implications before July 1, 2026.
{item.title}
{item.description}
